Vickers Vantage Corp. I is a Cayman Islands exempted company incorporated as a blank check company for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities, which we refer to throughout our prospectus as our initial business combination.

We intend to leverage the expertise and network of Vickers Venture Partners, or “VVP,” a venture capital firm affiliated with our executive officers, to take advantage of its deal flow, strong networks and technical expertise in assisting us in consummating an initial business combination. VVP was co-founded in 2005 by Dr. Jeffrey Chi, our Chairman and Chief Executive Officer, along with Dr. Finian Tan (an advisor of ours), Dr. Khalil Binebine, Ms. Linda Li, Dr. Damian Tan and Mr. Raymond Kong. VVP has offices in Singapore, Shanghai, San Francisco, New York and Hong Kong.

VVP is currently the most medaled venture capital firm in Singapore, having won five awards from the Singapore Venture Capital and Private Equity Association (SVCA) since the inception of the awards in 2010, and is also the 5th ranked most consistent top performing fund manager in the world according to Preqin’s database as of June 30, 2020.

We announced on March 17^th 2022 that we have entered into a definitive business combination agreement (“BCA”) with Scilex Holding Company (“Scilex”), a majority-owned subsidiary of Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”), a commercial biopharmaceutical company focused on developing and commercializing non-opioid therapies for patients with acute and chronic pain.

SEC Filings